These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1532212)

  • 1. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model.
    Jacobs SC; Stephenson JR; Wilkinson GW
    J Virol; 1992 Apr; 66(4):2086-95. PubMed ID: 1532212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1.
    Jacobs SC; Stephenson JR; Wilkinson GW
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2399-402. PubMed ID: 8077939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of gene coding for the NS1 protein of the tick-borne encephalitis virus in Escherichia coli cell].
    Pugachev KV; Pletnev AG
    Mol Biol (Mosk); 1990; 24(6):1631-9. PubMed ID: 2151283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein.
    Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Karganova GG; Elbert LB; Stephenson JR
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():689-95. PubMed ID: 9568962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
    Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
    Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.
    Pletnev AG; Bray M; Huggins J; Lai CJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10532-6. PubMed ID: 1438242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of the NS1 gene of tick-borne encephalitis virus in gram-negative bacteria from the mouse nasopharynx].
    Morozova OV; Maksimova TG; Popova RV; Martsinkevich ON; Bakhvalova VN
    Mol Biol (Mosk); 2001; 35(1):157-62. PubMed ID: 11234376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A recombinant adenovirus expressing the NS1 nonstructural protein of tick-borne encephalitis virus: some characteristics of the immunologic basis of antiviral action].
    Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Elbert LB; Stefenson JR
    Vopr Virusol; 1997; 42(5):219-22. PubMed ID: 9424847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses.
    Mandl CW; Heinz FX; Stöckl E; Kunz C
    Virology; 1989 Nov; 173(1):291-301. PubMed ID: 2554575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.
    Pletnev AG; Bray M; Lai CJ
    J Virol; 1993 Aug; 67(8):4956-63. PubMed ID: 8331735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of the genome region encoding the structural proteins and the NS1 protein of the tick borne encephalitis virus.
    Yamshchikov VF; Pletnev AG
    Nucleic Acids Res; 1988 Aug; 16(15):7750. PubMed ID: 2970626
    [No Abstract]   [Full Text] [Related]  

  • 15. The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection.
    Lindqvist R; Rosendal E; Weber E; Asghar N; Schreier S; Lenman A; Johansson M; Dobler G; Bestehorn M; Kröger A; Överby AK
    J Neuroinflammation; 2020 Sep; 17(1):284. PubMed ID: 32988388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
    Morozova OV; Maksimova TG; Bakhvalova VN
    Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant subolesin does not reduce tick infection with tick-borne encephalitis virus nor protect mice against disease.
    Havlíková S; Ličková M; Ayllón N; Roller L; Kazimírová M; Slovák M; Moreno-Cid JA; Pérez de la Lastra JM; Klempa B; de la Fuente J
    Vaccine; 2013 Mar; 31(12):1582-9. PubMed ID: 23357197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.
    Kreil TR; Maier E; Fraiss S; Eibl MM
    J Virol; 1998 Apr; 72(4):3076-81. PubMed ID: 9525632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
    Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
    Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.